ICON Public Limited Company(ICLR)Earnings, Financials & Key Ratios

ICLR•NASDAQ

$124.13

$9.48B mkt cap·13.0× P/E·Price updated May 6, 2026

SectorHealthcare IndustryDiagnostics & Research Sub-IndustryContract Research and Preclinical Services

AboutICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.Show more

Revenue$8.28B+2.0%
EBITDA$1.59B+2.9%
Net Income$791M+29.3%
EPS (Diluted)9.53+28.8%
Gross Margin29.42%-0.5%
EBITDA Margin19.15%+0.9%
Operating Margin13.26%+12.6%
Net Margin9.56%+26.7%
ROE8.44%+22.2%
ROIC6.49%+16.9%
Debt/Equity0.38-11.2%
Interest Coverage4.53+63.1%

Technical→

ICLR Key Insights

ICON Public Limited Company (ICLR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong 5Y profit CAGR of 16.2%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 24.2%
✓Trading at only 1.1x book value

✗Weaknesses

✗Weak momentum: RS Rating 20 (bottom 20%)
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ICLR Price & Volume

ICON Public Limited Company (ICLR) stock price & volume — 10-year historical chart

Loading chart...

ICLR Growth Metrics

ICON Public Limited Company (ICLR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years18.61%

5 Years24.17%

3 Years14.75%

TTM-2.46%

Profit CAGR

10 Years16.46%

5 Years16.18%

3 Years72.88%

TTM-19.84%

EPS CAGR

10 Years13.32%

5 Years7.01%

3 Years61.8%

TTM-17.61%

Return on Capital

10 Years16.47%

5 Years8.68%

3 Years6.62%

Last Year7.77%

ICLR Recent Earnings

ICON Public Limited Company (ICLR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 11/12 qtrs (92%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

Apr 29, 2026

EPS

$3.28

Est $3.19

+2.8%

Revenue

$2.0B

Est $2.0B

+0.5%

Q4 2025

Oct 22, 2025

EPS

$3.31

Est $3.28

+0.9%

Revenue

$2.0B

Est $2.0B

+3.0%

Q3 2025

Jul 23, 2025

EPS

$3.26

Est $3.19

+2.2%

Revenue

$2.0B

Est $2.0B

+1.8%

Q2 2025

Apr 30, 2025

EPS

$3.19

Est $3.11

+2.6%

Revenue

$2.0B

Est $2.0B

-0.3%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 29, 2026	$3.28vs $3.19+2.8%	$2.0Bvs $2.0B+0.5%
Q4 2025	Oct 22, 2025	$3.31vs $3.28+0.9%	$2.0Bvs $2.0B+3.0%
Q3 2025	Jul 23, 2025	$3.26vs $3.19+2.2%	$2.0Bvs $2.0B+1.8%
Q2 2025	Apr 30, 2025	$3.19vs $3.11+2.6%	$2.0Bvs $2.0B-0.3%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
CRLCharles River Laboratories International, Inc.Direct Competitor	8.97B	181.73	-62.45	-0.85%	-3.59%	-4.34%	0.95
IQVIQVIA Holdings Inc.Direct Competitor	29.95B	176.47	22.51	5.87%	8.33%	22.11%	2.44
MEDPMedpace Holdings, Inc.Direct Competitor	12.19B	426.79	27.93	19.97%	17.19%	120.89%	0.55
PRAProAssurance CorporationDirect Competitor	1.27B	24.60	24.85	-2.67%	6.04%	4.95%	0.32
LHLabcorp Holdings Inc.Product Competitor	21.14B	256.93	24.56	7.25%	6.66%	10.89%	0.83
DGXQuest Diagnostics IncorporatedProduct Competitor	20.93B	189.13	21.61	11.78%	9.08%	13.8%	0.95
NVCRNovoCure LimitedProduct Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
HIMSHims & Hers Health, Inc.Product Competitor	6.94B	26.88	52.71	59%	5.47%	23.73%	2.07

Compare ICLR vs Peers

ICON Public Limited Company (ICLR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CRL

Most directly comparable listed peer for ICLR.

Scale Benchmark

vs TMO

Larger-name benchmark to compare ICLR against a more recognizable public peer.

Peer Set

Compare Top 5

vs CRL, IQV, MEDP, PRA

ICLR Income Statement

ICON Public Limited Company (ICLR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Sales/Revenue	1.67B	1.76B	2.6B	2.81B	2.8B	5.48B	7.74B	8.12B	8.28B	8.1B
Revenue Growth %	5.81%	5.52%	47.62%	8.09%	-0.3%	95.93%	41.24%	4.89%	1.99%	-2.46%
Cost of Goods Sold	961.33M	1.03B	1.83B	1.97B	1.99B	3.97B	5.53B	5.72B	5.85B	5.93B
COGS % of Revenue	57.69%	58.66%	70.36%	70.36%	71.11%	72.48%	71.4%	70.44%	70.58%	-
Gross Profit	705.15M▲ 0%	726.96M▲ 3.1%	769.49M▲ 5.8%	831.7M▲ 8.1%	808.03M▼ 2.8%	1.51B▲ 86.7%	2.21B▲ 46.8%	2.4B▲ 8.4%	2.44B▲ 1.5%	2.18B▲ 0%
Gross Margin %	42.31%	41.34%	29.64%	29.64%	28.89%	27.52%	28.6%	29.56%	29.42%	26.85%
Gross Profit Growth %	5.88%	3.09%	5.85%	8.09%	-2.85%	86.65%	46.82%	8.39%	1.51%	-
Operating Expenses	393.46M	392.79M	392.37M	398.3M	416.06M	1.13B	1.42B	1.44B	1.34B	1.19B
OpEx % of Revenue	23.61%	22.34%	15.12%	14.2%	14.87%	20.61%	18.33%	17.78%	16.16%	-
Selling, General & Admin	325.73M	323.74M	325.79M	336.75M	341.69M	585.33M	778.75M	776.36M	728.35M	751.88M
SG&A % of Revenue	19.55%	18.41%	12.55%	12%	12.21%	10.68%	10.06%	9.56%	8.79%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	67.73M	69.05M	66.58M	61.55M	74.38M	544.36M	640.35M	667.72M	610.2M	3M
Operating Income	311.69M▲ 0%	338.34M▲ 8.5%	373.36M▲ 10.4%	433.41M▲ 16.1%	391.5M▼ 9.7%	378.53M▼ 3.3%	795.24M▲ 110.1%	956.15M▲ 20.2%	1.1B▲ 14.8%	984.7M▲ 0%
Operating Margin %	18.7%	19.24%	14.38%	15.45%	14%	6.91%	10.27%	11.77%	13.26%	12.15%
Operating Income Growth %	10.71%	8.55%	10.35%	16.08%	-9.67%	-3.31%	110.09%	20.23%	14.82%	-
EBITDA	371.27M	399.59M	439.27M	525.33M	486.11M	738.86M	1.41B	1.54B	1.59B	1.37B
EBITDA Margin %	22.28%	22.72%	16.92%	18.72%	17.38%	13.48%	18.21%	18.99%	19.15%	16.95%
EBITDA Growth %	9.45%	7.63%	9.93%	19.59%	-7.47%	51.99%	90.83%	9.37%	2.87%	-14.98%
D&A (Non-Cash Add-back)	59.58M	61.25M	65.92M	91.92M	94.61M	360.33M	614.73M	585.95M	488.5M	388.83M
EBIT	319.85M	340.68M	378.12M	440.26M	394.22M	379.1M	797.58M	935.49M	1.08B	789.96M
Net Interest Income	-11.52M	-10.28M	-8.74M	-6.42M	-10.29M	-181.85M	-227.39M	-331.69M	-228.63M	-192.57M
Interest Income	1.48M	2.35M	4.76M	6.86M	2.72M	574K	2.35M	5.01M	8.61M	6.86M
Interest Expense	13.01M	12.63M	13.5M	13.28M	13.02M	182.42M	229.73M	336.7M	237.24M	199.43M
Other Income/Expense	-11.52M	-10.28M	-8.74M	-6.42M	-10.66M	-184.01M	-230.52M	-331.69M	-228.63M	-363.13M
Pretax Income	300.17M▲ 0%	327.67M▲ 9.2%	368.38M▲ 12.4%	426.99M▲ 15.9%	380.84M▼ 10.8%	194.52M▼ 48.9%	564.72M▲ 190.3%	624.08M▲ 10.5%	869.18M▲ 39.3%	621.57M▲ 0%
Pretax Margin %	18.01%	18.63%	14.19%	15.22%	13.61%	3.55%	7.29%	7.69%	10.5%	7.67%
Income Tax	37.99M	46.57M	45.56M	51.13M	47.88M	41.33M	59.41M	11.75M	77.71M	22.09M
Effective Tax Rate %	12.66%	14.21%	12.37%	11.98%	12.57%	21.25%	10.52%	1.88%	8.94%	3.55%
Net Income	262.18M▲ 0%	281.49M▲ 7.4%	322.82M▲ 14.7%	373.99M▲ 15.9%	327.81M▼ 12.3%	153.19M▼ 53.3%	505.3M▲ 229.9%	612.34M▲ 21.2%	791.47M▲ 29.3%	599.48M▲ 0%
Net Margin %	15.73%	16.01%	12.44%	13.33%	11.72%	2.79%	6.53%	7.54%	9.56%	7.4%
Net Income Growth %	9.45%	7.36%	14.68%	15.85%	-12.35%	-53.27%	229.87%	21.18%	29.26%	-19.84%
Net Income (Continuing)	262.18M	281.49M	322.66M	375.86M	332.96M	153.19M	505.3M	612.34M	791.47M	599.48M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	4.65▲ 0%	5.13▲ 10.3%	5.90▲ 15.0%	6.79▲ 15.1%	6.24▼ 8.1%	2.25▼ 63.9%	6.13▲ 172.4%	7.40▲ 20.7%	9.53▲ 28.8%	7.68▲ 0%
EPS Growth %	17.13%	10.32%	15.01%	15.08%	-8.1%	-63.94%	172.44%	20.72%	28.78%	-17.61%
EPS (Basic)	4.75	5.20	5.96	6.85	6.29	2.28	6.20	7.46	9.60	-
Diluted Shares Outstanding	56.41M	54.87M	54.74M	54.33M	53.28M	68.07M	82.47M	82.72M	83.03M	78.08M
Basic Shares Outstanding	55.25M	54.13M	54.12M	53.86M	52.86M	67.11M	81.53M	82.1M	82.48M	77.37M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

ICLR Balance Sheet

ICON Public Limited Company (ICLR) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Total Current Assets	957.96M	1.1B	1.33B	1.62B	2.1B	2.94B	3.23B	3.41B	3.53B	3.41B
Cash & Short-Term Investments	260.59M	360.45M	455.76M	569.94M	842.03M	753.92M	290.48M	380.06M	538.78M	468.89M
Cash Only	192.54M	282.86M	395.85M	520.31M	840.3M	752.21M	288.77M	378.1M	538.78M	468.89M
Short-Term Investments	68.05M	77.59M	59.91M	49.63M	1.73M	1.71M	1.71M	1.95M	0	0
Accounts Receivable	662.2M	706.19M	837.62M	1.01B	1.21B	2.07B	2.8B	2.9B	2.85B	2.8B
Days Sales Outstanding	145.04	146.58	117.78	131.85	157.55	138.05	132.09	130.32	125.66	125.71
Inventory	2.4M	2.2M	2.3M	3.2M	0	0	7.06M	0	0	0
Days Inventory Outstanding	0.91	0.78	0.46	0.59	-	-	0.47	-	-	-
Other Current Assets	-2.4M	0	0	-3.2M	0	0	130.03M	132.1M	140.44M	140.71M
Total Non-Current Assets	867.88M	1.07B	1.02B	1.28B	1.33B	14.45B	13.96B	13.58B	13.35B	13.1B
Property, Plant & Equipment	148.97M	105.1M	103.71M	270.06M	258.9M	534.57M	504.15M	501.52M	530.48M	525.18M
Fixed Asset Turnover	11.19x	16.73x	25.03x	10.39x	10.80x	10.25x	15.36x	16.19x	15.61x	15.44x
Goodwill	616.09M	783.07M	770.27M	883.17M	936.26M	9.04B	8.97B	9.02B	9.05B	8.93B
Intangible Assets	56.61M	129.58M	109.01M	67.89M	66.46M	4.71B	4.28B	3.86B	3.56B	3.38B
Long-Term Investments	0	0	6.96M	10.05M	20.3M	24.96M	32.63M	46.8M	57.95M	434.1M
Other Non-Current Assets	26.53M	22.36M	2.45M	34.67M	38M	89.19M	92.17M	78.47M	72.8M	147.92M
Total Assets	1.83B▲ 0%	2.19B▲ 19.7%	2.35B▲ 7.7%	2.91B▲ 23.5%	3.44B▲ 18.2%	17.39B▲ 406.1%	17.19B▼ 1.2%	16.99B▼ 1.1%	16.88B▼ 0.7%	16.51B▲ 0%
Asset Turnover	0.91x	0.80x	1.10x	0.97x	0.81x	0.32x	0.45x	0.48x	0.49x	0.49x
Asset Growth %	6.22%	19.72%	7.7%	23.5%	18.16%	406.09%	-1.16%	-1.14%	-0.66%	-8.82%
Total Current Liabilities	494.41M	566.06M	610.62M	1.13B	1.12B	2.48B	2.69B	2.83B	2.8B	3.22B
Accounts Payable	8.7M	18.59M	13.29M	24.05M	51.11M	226.98M	611.4M	595.47M	704.59M	113.29M
Days Payables Outstanding	3.3	6.58	2.66	4.45	9.38	20.85	40.38	38	44	15.87
Short-Term Debt	0	0	0	349.64M	0	55.15M	55.15M	110.15M	29.76M	567.86M
Deferred Revenue (Current)	272.81M	299.03M	274.51M	367.03M	660.93M	1.32B	1.51B	1.65B	1.61B	6.15B
Other Current Liabilities	190.67M	233.47M	317.1M	350.18M	375.39M	439.82M	24.82M	415.06M	355.22M	960.37M
Current Ratio	1.94x	1.95x	2.18x	1.44x	1.87x	1.19x	1.20x	1.21x	1.26x	1.26x
Quick Ratio	1.93x	1.94x	2.17x	1.43x	1.87x	1.19x	1.20x	1.21x	1.26x	1.26x
Cash Conversion Cycle	142.65	140.78	115.58	127.99	-	-	92.18	-	-	109.84
Total Non-Current Liabilities	607.91M	389.56M	389.35M	158.21M	461.43M	6.84B	6B	4.92B	4.56B	3.95B
Long-Term Debt	348.51M	348.89M	349.26M	0	348.48M	5.38B	4.6B	3.67B	3.4B	2.88B
Capital Lease Obligations	221.65M	0	0	76.59M	60.8M	159.48M	131.64M	126.32M	140.09M	536.26M
Deferred Tax Liabilities	4.63M	7.72M	8.21M	9.48M	10.41M	1.09B	988.59M	899.1M	812.49M	3.12B
Other Non-Current Liabilities	32.23M	31.99M	31M	71.32M	40.91M	213.97M	277.45M	232.65M	209.3M	827.84M
Total Liabilities	880.67M	955.62M	999.97M	1.29B	1.59B	9.32B	8.69B	7.75B	7.35B	7.17B
Total Debt	348.51M	348.89M	349.26M	454.55M	433.61M	5.65B	4.83B	3.94B	3.6B	3.57B
Net Debt	155.97M	66.03M	-46.59M	-65.76M	-406.69M	4.89B	4.54B	3.56B	3.06B	3.1B
Debt / Equity	0.37x	0.28x	0.26x	0.28x	0.23x	0.70x	0.57x	0.43x	0.38x	0.38x
Debt / EBITDA	0.94x	0.87x	0.80x	0.87x	0.89x	7.64x	3.43x	2.55x	2.27x	2.60x
Net Debt / EBITDA	0.42x	0.17x	-0.11x	-0.13x	-0.84x	6.62x	3.22x	2.31x	1.93x	1.93x
Interest Coverage	24.59x	26.98x	28.00x	33.16x	30.28x	2.08x	3.47x	2.78x	4.53x	3.96x
Total Equity	945.17M▲ 0%	1.23B▲ 30.2%	1.35B▲ 10.1%	1.62B▲ 19.5%	1.85B▲ 14.3%	8.07B▲ 336.0%	8.5B▲ 5.3%	9.24B▲ 8.7%	9.52B▲ 3.1%	9.33B▲ 0%
Equity Growth %	23.68%	30.16%	10.08%	19.48%	14.35%	335.99%	5.34%	8.74%	3.05%	-1.03%
Book Value per Share	16.76	22.42	24.74	29.78	34.72	118.51	103.05	111.71	114.69	119.55
Total Shareholders' Equity	945.17M	1.19B	1.35B	1.62B	1.85B	8.07B	8.5B	9.24B	9.52B	9.33B
Common Stock	4.61M	4.66M	4.66M	4.63M	4.58M	6.64M	6.65M	6.7M	6.59M	6.29M
Retained Earnings	587.85M	742.8M	888.33M	1.11B	1.26B	1.42B	1.82B	2.43B	2.72B	2.31B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-86.3M	-37.8M	-69.33M	-75.82M	-35.48M	-90.94M	-171.54M	-142.34M	-228.63M	-85.34M
Minority Interest	0	0	0	0	0	0	0	0	0	0

ICLR Cash Flow Statement

ICON Public Limited Company (ICLR) cash flow — operating, investing & free cash flow history

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Cash from Operations	259.2M	383.08M	264.01M	412.54M	594.72M	829.14M	563.32M	1.16B	1.29B	1.29B
Operating CF Margin %	15.55%	21.79%	10.17%	14.7%	21.26%	15.13%	7.28%	14.3%	15.54%	-
Operating CF Growth %	-7.27%	47.79%	-31.08%	56.26%	44.16%	39.42%	-32.06%	106.11%	10.82%	-65.47%
Net Income	262.18M	24.23M	322.82M	375.86M	331.43M	153.19M	505.3M	612.34M	791.47M	599.48M
Depreciation & Amortization	59.58M	191K	65.92M	61.55M	95.07M	314.99M	569.51M	585.95M	528.29M	388.83M
Stock-Based Compensation	40.34M	21.63M	28.06M	26.82M	26.27M	133.84M	70.52M	55.67M	45.87M	92.47M
Deferred Taxes	1.54M	10.73M	45.56M	-1.54M	50.75M	-60.62M	-124.98M	-85.4M	0	-90.01M
Other Non-Cash Items	-1.12M	323.61M	-20.68M	32.6M	-23.51M	152.75M	93.18M	107.3M	-22.47M	244.53M
Working Capital Changes	-103.31M	2.69M	-177.65M	-82.74M	114.71M	135M	-550.22M	-114.82M	-56.51M	-58.03M
Change in Receivables	2.53M	57.75M	-37.56M	-101.55M	-175.04M	95.86M	-753.29M	-78.58M	9.39M	106.03M
Change in Inventory	-62.11M	-45.19M	-38K	-69.7M	-1.63M	0	0	0	0	0
Change in Payables	1.18M	2.53M	-5.07M	3.44M	26.49M	0	0	0	0	0
Cash from Investing	-74.81M	-177.81M	-37.3M	-162.03M	-46.58M	-6.02B	-145.87M	-226.65M	-266.79M	-206.53M
Capital Expenditures	-42.6M	-28K	-48.4M	-50.65M	-51.05M	-93.75M	-142.16M	-140.69M	-168.06M	-181.46M
CapEx % of Revenue	2.56%	0%	1.86%	1.8%	1.83%	1.71%	1.84%	1.73%	2.03%	-
Acquisitions	-51.04M	89.8M	-1.65M	-119.58M	-40.21M	-5.92B	-1.91M	-71.77M	-84.16M	-1.18M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-258.97M	0	0	0	-10M	1.91M	0	0	86.24K
Cash from Financing	-93.71M	-119.28M	-108.4M	-125.41M	-235.02M	5.11B	-864.17M	-844.04M	-837.18M	-1.2B
Debt Issued (Net)	0	0	0	0	0	5.03B	-800M	-895M	-360.28M	-30.79M
Equity Issued (Net)	-110M	-133.11M	-128.96M	-146.93M	-175M	117.74M	-99.98M	50.96M	-500M	-1.18B
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-110M	-133.11M	-128.96M	-146.93M	-175M	0	-99.98M	0	-500M	-1.18B
Other Financing	16.29M	13.83M	20.56M	21.52M	-60.02M	-30.33M	35.81M	0	23.1M	8.09M
Net Change in Cash	88.63M▲ 0%	90.32M▲ 1.9%	112.99M▲ 25.1%	124.46M▲ 10.1%	320M▲ 157.1%	-88.09M▼ 127.5%	-463.44M▼ 426.1%	89.33M▲ 119.3%	160.68M▲ 79.9%	-226.62M▲ 0%
Free Cash Flow	216.6M▲ 0%	48.71M▼ 77.5%	215.62M▲ 342.6%	361.9M▲ 67.8%	543.67M▲ 50.2%	735.39M▲ 35.3%	421.15M▼ 42.7%	1.02B▲ 142.3%	1.12B▲ 9.6%	995.8M▲ 0%
FCF Margin %	13%	2.77%	8.31%	12.9%	19.44%	13.42%	5.44%	12.57%	13.51%	12.29%
FCF Growth %	-5.74%	-77.51%	342.63%	67.84%	50.23%	35.26%	-42.73%	142.27%	9.63%	-18.97%
FCF per Share	3.84	0.89	3.94	6.66	10.20	10.80	5.11	12.34	13.47	13.47
FCF Conversion (FCF/Net Income)	0.99x	1.36x	0.82x	1.10x	1.81x	5.41x	1.11x	1.90x	1.63x	1.66x
Interest Paid	13.62M	13.09M	13.06M	13.06M	13.06M	106.2M	210.92M	317.98M	0	0
Taxes Paid	10.21M	12.3M	18.56M	29.84M	27.6M	55.1M	116.32M	163.78M	0	0

ICLR Key Ratios

ICON Public Limited Company (ICLR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
Return on Equity (ROE)	30.68%	25.88%	24.98%	25.16%	18.9%	3.09%	6.1%	6.9%	8.44%	6.32%
Return on Invested Capital (ROIC)	22.14%	21.17%	21.51%	22.73%	19.6%	3.94%	4.59%	5.55%	6.49%	6.49%
Gross Margin	42.31%	41.34%	29.64%	29.64%	28.89%	27.52%	28.6%	29.56%	29.42%	26.85%
Net Margin	15.73%	16.01%	12.44%	13.33%	11.72%	2.79%	6.53%	7.54%	9.56%	7.4%
Debt / Equity	0.37x	0.28x	0.26x	0.28x	0.23x	0.70x	0.57x	0.43x	0.38x	0.38x
Interest Coverage	24.59x	26.98x	28.00x	33.16x	30.28x	2.08x	3.47x	2.78x	4.53x	3.96x
FCF Conversion	0.99x	1.36x	0.82x	1.10x	1.81x	5.41x	1.11x	1.90x	1.63x	1.66x
Revenue Growth	5.81%	5.52%	47.62%	8.09%	-0.3%	95.93%	41.24%	4.89%	1.99%	-2.46%

ICLR Frequently Asked Questions

ICON Public Limited Company (ICLR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

ICON Public Limited Company (ICLR) reported $8.10B in revenue for fiscal year 2024. This represents a 14421% increase from $55.8M in 1998.

ICON Public Limited Company (ICLR) grew revenue by 2.0% over the past year. Growth has been modest.

Yes, ICON Public Limited Company (ICLR) is profitable, generating $599.5M in net income for fiscal year 2024 (9.6% net margin).

Dividend & Returns

ICON Public Limited Company (ICLR) has a return on equity (ROE) of 8.4%. This is below average, suggesting room for improvement.

ICON Public Limited Company (ICLR) generated $995.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ICLR

ICON Public Limited Company (ICLR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

ICON Public Limited Company(ICLR)Earnings, Financials & Key Ratios

ICLR Key Insights

✓Strengths

✗Weaknesses

ICLR Price & Volume

ICLR Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ICLR Recent Earnings

ICLR Peer Comparison

Compare ICLR vs Peers

vs CRL

vs TMO

Compare Top 5

ICLR Income Statement

ICLR Balance Sheet

ICLR Cash Flow Statement

ICLR Key Ratios

ICLR Frequently Asked Questions

Explore More ICLR

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation